Novartis – Latest stories from Nourish

a { color: #880000 !important; background: #ffeeee !important; } Latest News from NourishThe Nourish Mission (formerly OneSub)Get answers to today's big questionsWhy is Novartis in the news at the moment?

Novartis just got FDA approval for a new immune disorder drug, boosting its pharma game. Swiss giant based in Basel, 8th largest by revenue in 2024.

Stories involving Novartis

UK Pharma Industry Faces Investment Collapse

Major pharmaceutical firms have paused or canceled over £2bn in UK investments this year amid concerns over drug pricing policies, US pressure for price parity, and a deteriorating investment climate. Industry warnings highlight risks to future drug development and supply chains.

US Imposes New Tariffs on Trucks, Steel, and Goods

The US has announced new tariffs on heavy trucks, steel, aluminum, and various finished goods, citing national security. The move affects European and Mexican industries, with concerns over supply chains and trade relations. The tariffs take effect from October 1, 2025, amid ongoing global trade tensions.

FDA Approves New Urticaria Drug

The FDA has approved remibrutinib, marketed as Rhapsido, for adults with chronic spontaneous urticaria, a condition affecting sleep, work, and mental health. This marks a new treatment option, expanding the therapeutic landscape for this non-life-threatening but impactful condition.

Pfizer Wins Bid for Metsera

Pfizer has agreed to acquire Metsera Inc., a biotech developing obesity treatments, for up to $86.25 per share, defeating a rival bid from Novo Nordisk amid a competitive market for weight-loss drugs. The deal follows a bidding war and regulatory concerns.